One of the largest food retailers in the world—and the fourth biggest in this country—got itself into hot water with the U.S. Department of Justice for allegedly cheating on drug prices it charges to federal healthcare programs.
Tamin Naber, MD, was charged with simple assault for biting a former employee at his medical practice who was suing him for wrongful termination. The incident occurred in November 2025.
The money includes $238.6 million to improve suicide crisis hotlines and $223.1 million to expand community behavioral health clinics. Dozens of programs around the country are set to receive the funding.
A recent investigation from KFF Health News about payments to members of an FDA panel evaluating an Abbott Laboratories cardiac device is raising eyebrows.
Key collaborators across the healthcare AI life cycle now have a common set of principles to which they can hold each other. And that means everyone from developers and researchers to providers, regulators and even patients.
CMS must ensure transparency, clarity and predictability by providing detailed guidance on comparator drug selection and the evaluation of evidence, according to a group of D.C.-based health policy researchers.
Bumping up hard against the reality of depleted data sources, three of AI’s top players have been acting like they’ve had no choice but to consider cutting corners.
